Literature DB >> 2120437

Characteristics of IgG antiphospholipid antibodies in patients with systemic lupus erythematosus and syphilis.

R A Levy1, A E Gharavi, L R Sammaritano, L Habina, T Qamar, M D Lockshin.   

Abstract

To evaluate the similarities and differences of antiphospholipid antibodies (aPL) in systemic lupus erythematosus (SLE) and syphilis, we studied 20 SLE and 16 syphilis high titer IgG aPL sera for antibody isotype, avidity, phospholipid specificity, light chain and IgG subclass. Syphilis aPL had lower avidity, with kappa light chain and IgG1 and IgG3 predominance, in contrast to higher avidity, with lambda light chain and IgG2 and IgG4 predominance in SLE aPL. Phospholipid specificities were similar. SLE and syphilis aPL both recognize phospholipid epitopes but differ in important antibody characteristics.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2120437

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  [Female patient with Sjoegren's syndrome and cardiolipin antibodies].

Authors:  S Vilardi; K Muth; M Uppenkamp; R Bergner
Journal:  Internist (Berl)       Date:  2011-06       Impact factor: 0.743

2.  Differences in functional activity of anticardiolipin antibodies from patients with syphilis and those with antiphospholipid syndrome.

Authors:  S S Pierangeli; G H Goldsmith; S Krnic; E N Harris
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

3.  IgG2 subclass restriction of anti-beta 2 glycoprotein 1 antibodies in autoimmune patients.

Authors:  J Arvieux; B Roussel; D Ponard; M G Colomb
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

4.  Induction of antiphospholipid autoantibodies by immunization with beta 2 glycoprotein I (apolipoprotein H).

Authors:  A E Gharavi; L R Sammaritano; J Wen; K B Elkon
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders.

Authors:  S Loizou; C Cofiner; A P Weetman; M J Walport
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

Review 6.  Antiphospholipid syndrome.

Authors:  Sanjay C Keswani; Naresh Chauhan
Journal:  J R Soc Med       Date:  2002-07       Impact factor: 18.000

7.  Lupus anticoagulant (LA) in pregnant women with history of recurrent fetal loss.

Authors:  Ja Olaniyi; Sa Olomu; Oa Finomo
Journal:  J Blood Med       Date:  2011-05-30

Review 8.  Untangling the Intricacies of Infection, Thrombosis, Vaccination, and Antiphospholipid Antibodies for COVID-19.

Authors:  Nevio Cimolai
Journal:  SN Compr Clin Med       Date:  2021-06-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.